Determinants of bone mass in systemic lupus erythematosus: a cross sectional study on premenopausal women.

Abstract

Osteoporosis is a frequent feature in young patients with SLE. Disease duration is associated with an increased risk for osteoporosis, but the role of glucocorticoid treatment seems to be crucial. Steroid exposure was the only treatment related variable exerting an influence on the development of osteoporosis.